1116
Oxidation of 3-Amino-9-ethylcarbazole 5 with Frémy’s Salt An
aqueous solution (200 ml) of Frémy’s salt (3.2 g, 11.9 mmol) and potassium
dihydrogen orthophosphate (0.16 g, 1.19 mmol) was added to a solution of
aminocarbazole 5 (1 g, 4.76 mmol) in acetone (200 ml). The reaction mix-
ture was stirred at room temperature for 1 h, extracted with CH2Cl2, dried
over MgSO4 and concentrated under vacuum. The crude residue was purified
by column chromatography on silica gel using CH3COOEt/Petroleum ether
(20 : 80) as the eluent to give compounds 12 and 13.
Vol. 52, No. 9
yellow solid in 49% yield, mp 182 °C. IR (KBr) cmꢁ1: 3260 1700, 1640. 1H-
NMR (CDCl3) d: 8.9 (1H, s, NH), 7.87 (1H, d, Jꢂ7.9 Hz, H-11), 7.55—7.20
(3H, m, H-8, H-9, H-10), 6.1 (1H, t, Jꢂ5.3, 3.0 Hz, H-2 or H-3), 5.58 (1H, t,
Jꢂ5.3, 3.0 Hz, H-2 or H-3), 4.1 (1H, dd, Jꢂ7.2, 3.8 Hz, H-11c), 3.59 (2H, s,
H-1, H-4), 3.42 (1H, dd, Jꢂ7.2, 3.8 Hz, H-4a), 1.71 (2H, s, H-12). 13C-NMR
(DMSO-d6) d: 199.1, 172.2, 140.8, 136.3, 135.2, 134.9, 129.4, 126.1, 124.6,
123.4, 121.4, 113.9, 51.5, 49.8, 49.1, 48.2, 37.4. Anal. Calcd for
C17H13NO2·0.7 H2O: C, 74.00; H, 5.26; N, 5.07. Found: C, 73.98; H, 4.89;
N, 5.23.
3-Amino-9-ethyl-1-[(9-ethyl-9H-carbazol-3-yl)imino]-1,9-dihydro-4H-
carbazol-4-one (12) Compound 12 was obtained as a dark red solid in
11-Ethyl-1,4-dihydro-1,4-methanobenzo[a]carbazole-5,6(11H)-dione
(19) Freshly distilled cyclopentadiene 17 (0.4 g, 6.06 mmol) was added
dropwise to a solution of the carbazoledione 7 (0.15 g, 0.67 mmol) in
CH2Cl2 (6 ml) stirred and cooled at 0 °C. The stirring was continued for 6 h
at 0 °C. Then, 1.5 g of SiO2 was added and the reaction mixture was stirred
for 48 h at 40 °C. The mixture was filtered and SiO2 washed with CH2Cl2.
The combined filtrates were concentrated under vacuum. Column chro-
matography of the residue, eluting with a mixture of CH2Cl2/MeOH (98 : 2)
gave compound 19 as a dark green solid in 26% yield, mp 191 °C (decomp.).
1
10% yield, mp 236 °C. IR (KBr) cmꢁ1: 3460, 3360, 1635, 1595. H-NMR
(DMSO-d6) d: 8.19 (2H, d, Jꢂ7.4 Hz, H), 7.77 (1H, d, Jꢂ7.4 Hz), 7.76 (1H,
s, H-4ꢃ), 7.68 (1H, d, Jꢂ8.5 Hz), 7.62 (1H, d, Jꢂ8.5 Hz), 7.49—7.33 (3H,
m), 7.21—7.13 (2H, m), 6.34 (2H, br s, NH2), 5.93 (1H, s, H-2), 4.96 (2H, q,
Jꢂ7.0 Hz, CH2CH3), 4.48 (2H, q, Jꢂ7.0 Hz, CH2CH3), 1.45 (3H, t,
Jꢂ7.0 Hz, CH2CH3), 1.36 (3H, t, Jꢂ7.0 Hz, CH2CH3). Anal. Calcd for
C28H24N4O·0.4 H2O: C, 76.48; H, 5.68; N, 12.74. Found: C, 76.51; H, 5.73;
N, 12.59.
IR (KBr) cmꢁ1: 1625. H-NMR (CDCl3) d: 8.15 (1H, m, Jꢂ7.9, 1.1 Hz, H-
1
3-Amino-9-ethyl-1-[(9-ethyl-4-hydroxy-9H-carbazol-3-yl)imino]-1,9-
dihydro-4H-carbazol-4-one (13) Compound 13 was obtained as a dark
blue solid in 30% yield, mp 248 °C. IR (KBr) cmꢁ1: 3500, 3380, 1625, 1585,
7), 7.34—7.25 (3H, m, H-8, H-9, H-10), 6.96 (1H, dd, Jꢂ4.9, 3.2 Hz, H-2 or
H-3), 6.82 (1H, dd, Jꢂ4.9, 3.2 Hz, H-2 or H-3), 4.45 (2H, q, Jꢂ7.4 Hz,
CH2CH3), 4.33 (1H, s, H-1 or H-4), 4.16 (1H, s, H-1 or H-4), 2.36 (2H, m,
H-12), 1.58 (3H, t, Jꢂ7.4 Hz, CH2CH3). 13C-NMR (DMSO-d6) d: 178.6,
176.4, 160.9, 151.4, 151.2, 144.4, 141.2, 138.8, 126.8, 125.6, 125.3, 121.2,
112.7, 111.3, 71.0, 52.3, 47.8, 17.1. Anal. Calcd for C19H15NO2·0.5 H2O: C,
76.49; H, 5.41; N, 4.69. Found: C, 76.56; H, 5.29; N, 4.67.
1
1550. H-NMR (DMSO-d6) d: 9 (1H, s, OH), 8.26 (1H, d, Jꢂ7.4 Hz), 8.19
(1H, d, Jꢂ7.4 Hz), 7.75 (1H, d, Jꢂ8.1 Hz), 7.57 (1H, d, Jꢂ8.1 Hz), 7.44—
7.32 (3H, m), 7.19 (1H, m), 7.14 (1H, d, Jꢂ8.5 Hz), 7.01 (1H, d, Jꢂ8.5 Hz),
6.32 (2H, br s, NH2), 6.04 (1H, s, H-2), 5.03 (2H, q, Jꢂ7.0 Hz, CH2CH3),
4.42 (2H, q, Jꢂ7.4 Hz, CH2CH3), 1.41 (3H, t, Jꢂ7.4 Hz, CH2CH3), 1.35
(3H, t, Jꢂ7.0 Hz, CH2CH3). FAB-MS m/z 449 (MꢀH)ꢀ. Anal. Calcd for
C28H24N4O2·0.4 H2O: C, 73.79; H, 5.49; N, 12.29. Found: C, 73.87; H, 5.41;
N, 12.36.
Acknowledgments We thank Pr. Houda Fillion for her encouragement
and for the help she has given us in the preparation of the manuscript.
Benzo[c]carbazole-5,6(7H)-dione (15) 1-Acetoxy-1,3-butadiene 14
(0.503 g, 4.5 mmol) in dry THF (1 ml) was added dropwise to a solution of
carbazoledione 3 (0.3 g, 1.52 mmol) in 14 ml of the same solvent. The reac-
tion mixture was stirred at reflux for 15 h. The solvent was evaporated off to
afford a residue which was purified by column chromatography on silica gel
with CH2Cl2/MeOH (95 : 5) as the eluent to give compound 15 as a black
solid in 56% yield, mp ꢄ300 °C. IR (KBr) cmꢁ1: 3320, 1710, 1680. 1H-
NMR (CDCl3) d: 12.4 (1H, s, NH), 8.29 (1H, d, Jꢂ8.3 Hz), 8.18 (1H, d,
Jꢂ7.6 Hz), 7.89 (1H, dd, Jꢂ7.5, 1.3 Hz), 7.68 (1H, td, Jꢂ7.6, 1.3 Hz), 7.44
(2H, m), 7.34 (1H, td, Jꢂ7.5, 1.0 Hz), 7.25 (1H, td, Jꢂ6.6, 1.5 Hz). 13C-
NMR (DMSO-d6) d: 181.5, 172.3, 141.0, 136.4, 135.7, 132.9, 130.6, 130.5,
128.5, 127.9, 125.6, 123.9, 123.8, 123.3, 122.2, 114.7. Anal. Calcd for
C16H9NO2·0.3 H2O: C, 76.06; H, 3.83; N, 5.54. Found: C, 76.38; H, 4.05; N,
5.55.
11-Ethylbenzo[a]carbazole-5,6(11H)-dione (16) Synthesis of com-
pound 16 was performed starting from 7 following the procedure used for
15. Compound 16 was purified by column chromatography on silica gel with
CH2Cl2/MeOH (98 : 2) as the eluent and obtained as an orange solid in 35%
yield, mp 255 °C. IR (KBr) cmꢁ1: 1690, 1630. 1H-NMR (CDCl3) d: 8.30
(1H, dd, Jꢂ6.6, 1.8 Hz), 8.16 (1H, dd, Jꢂ7.6, 1.0 Hz), 7.80 (1H, d,
Jꢂ7.9 Hz), 7.68 (1H, td, Jꢂ7.6, 1.3 Hz), 7.46 (1H, t, Jꢂ7.4 Hz), 7.40—7.28
(3H, m), 4.59 (2H, q, Jꢂ7.3 Hz, CH2CH3), 1.69 (3H, t, Jꢂ7.3 Hz, CH2CH3).
13C-NMR (DMSO-d6) d: 182.4, 174.5, 151.3, 143.6, 139.7, 136.3, 132.1,
131.2, 130.8, 129.9, 125.9, 125.82, 125.2, 121.9, 115.1, 112.4, 41.5, 15.6.
Anal. Calcd for C18H13NO2·0.25 H2O: C, 77.26; H, 4.86; N, 5.00. Found: C,
77.31; H, 4.80; N, 4.78.
References
1) Knölker H.-J., Reddy K. R., Chem. Rev., 102, 4303—4427 (2002).
2) Shin-ya K., Tanaka M., Furihata K., Hayakawa Y., Seto H., Tetrahe-
dron Lett., 34, 4943—4944 (1993).
3) Shin-ya K., Kunigami T., Kim J.-S., Furihata K., Hayakawa Y., Seto
H., Biosci. Biotech. Biochem., 61, 1768—1769 (1997).
4) Shin-ya K., Shimizu S., Kunigami T., Furihata K., Seto H., J. Antibiot.,
48, 574—578 (1995).
5) Tanaka M., Shin-ya K., Furihata K., Seto H., J. Antibiot., 48, 326—
328 (1995).
6) Bouaziz Z., Nebois P., Poumaroux A., Fillion H., Heterocycles, 52,
977—999 (2000).
7) Poumaroux A., Bouaziz Z., Domard M., Fillion H., Heterocycles, 45,
585—596 (1997).
8) Poumaroux A., Bouaziz Z., Fillion H., Domard M., Giraud J., Pétavy
A.-F., Chem. Pharm. Bull., 47, 643—646 (1999).
9) Aouacheria A., Néel B., Bouaziz Z., Dominique R., Walchshofer N.,
Paris J., Fillion H., Gillet G., Biochem. Pharmacol., 64, 1605—1616
(2002).
10) Bouaziz Z., Ghérardi A., Régnier F., Sarciron M.-E., Bertheau X.,
Fenet B., Walchshofer N., Fillion H., Eur. J. Org. Chem., 11, 1834—
1838 (2002).
11) Teuber H.-J., Staiger G., Chem. Ber., 87, 1251—1254 (1954).
12) Albanese D., Landini D., Penso M., Spano G., Trebicka A., Tetrahe-
dron, 51, 5681—5688 (1995).
1,4,4a,11c-Tetrahydro-1,4-methanobenzo[c]carbazole-5,6(7H)-dione
(18) Freshly distilled cyclopentadiene 17 (1.05 g, 15.9 mmol) was added
dropwise to a solution of the carbazoledione 3 (1 g, 5.3 mmol) in CH2Cl2
(40 ml) stirred and cooled at ꢁ10 °C. The stirring was continued for 5 h at
ꢁ10 °C then for 12 h at room temperature. The solution was concentrated
under vacuum and the resulting residue was chromatographed on silica gel
using CH2Cl2/MeOH (97 : 3) as the eluent. Compound 18 was obtained as a
13) Teuber H.-J., Jellinek G., Chem. Ber., 87, 1841—1848 (1954).
14) Horner L., Sturm K., Chem. Ber., 88, 329—338 (1955).
15) Nebois P., Cherkaoui O., Benameur L., Fillion H., Fenet B., Tetrahe-
dron, 50, 8457—8464 (1994).
16) Bernardes Genisson V., Nebois P., Domard M., Fillion H., Chem.
Pharm. Bull., 48, 893—894 (2000).